Trial Profile
Comparison of the long-term efficacy of silodosin and tamsulodin for the tratment of benign prostatic hyperplasia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2018
Price :
$35
*
At a glance
- Drugs Silodosin (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 01 Feb 2018 Status changed from active, no longer recruiting to completed.
- 07 Aug 2012 New trial record